JNK

JNK(c-Jun N 端激酶)是 MAPK 的一个激酶亚家族,在各种应激刺激下被激活,具有多种调节功能。JNK 丝氨酸/苏氨酸蛋白激酶家族包含三种亚型(JNK1、JNK2 和 JNK3)。JNK 参与多种病理的出现和发展,如神经退行性疾病、心血管疾病和代谢性疾病以及炎症和癌症。

与其他 MAP 激酶类似,JNK 由磷酸化级联激活,通常涉及两种类型的上游激酶,即所谓的 MAP 激酶激酶激酶(MAP3K、MKKK)和 MAP 激酶激酶(MAP2K;MKK)。在 MAP2K 水平上,JNK 由 MKK4 和 MKK7 激活,前者是 JNK 和 p38 MAP 激酶信号通路的共同激活剂。JNK 级联与其他通路共享各种交叉点,使其成为复杂信号网络的一部分。

JNK (c-Jun N-terminal kinase), a kinase subfamily belonging to the MAPK, is activated in response to various stress stimuli and possesses a wide variety of regulatory functions. The JNK family of serine/threonine protein kinases comprises three isoforms (JNK1, JNK2 and JNK3). JNKs are involved in the emergence and progression of diverse pathologies such as neurodegenerative, cardiovascular and metabolic disorders as well as inflammation and cancer.

Similar to the other MAP kinases, JNKs are activated by a phosphorylation cascade generally involving two types of upstream kinases, the so-called MAP kinase kinase kinases (MAP3K, MKKK) and the MAP kinase kinases (MAP2K; MKK). At the MAP2K level, JNKs are activated by MKK4 and MKK7, the former is a common activator of the JNK and the p38 MAP kinase signaling pathway. The JNK cascade shares various intersection points with other pathways making it a part of a complex signaling network.

共 3种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
D-JBD19

D-JBD19 是一种不可渗透性的多肽,作为 JNK 抑制剂 D-JNKI1 (MS-L89570) 的无活性对照,而 D-JNKI1 具有神经保护作用。

954134-42-0
Control
99.84%
D-JBD19
D-JBD19 TFA

D-JBD19 TFA 是一种不可渗透性的多肽,具有神经保护作用。

Control
D-JBD19 TFA
SP 600125, negative control
JNK Inhibitor II, negative control

SP 600125, negative control (SPM1) 是一种吡唑蒽酮的烷基衍生物,可作为 SP600125 (MS-X95304) 的阴性对照。

54642-23-8
Control
98.05%
SP 600125, negative control

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础